Global Alfentanil Hydrochloride Injection Market Research Report 2024

Publication ID:

PB508243634

Publication Date:

August 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Alfentanil Hydrochloride Injection is an opioid analgesic (pain reliever) indicated as an analgesic adjunct given in incremental doses in the maintenance of anesthesia with barbiturate/nitrous oxide/oxygen; as an analgesic administered by continuous infusion with nitrous oxide/oxygen in the maintenance of general anesthesia; as a primary anesthetic agent for the induction of anesthesia in patients undergoing general surgery in which endotracheal intubation and mechanical ventilation are required; and as the analgesic component for monitored anesthesia care (MAC).
The global Alfentanil Hydrochloride Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Alfentanil Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alfentanil Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Alfentanil Hydrochloride Injection include Piramal Pharma, Yichang Humanwell Pharmaceutical, Hameln Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Alfentanil Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alfentanil Hydrochloride Injection.
The Alfentanil Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Alfentanil Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Specification, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alfentanil Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Specification, by Application, and by regions.
By Company
Piramal Pharma
Yichang Humanwell Pharmaceutical
Hameln Pharma
Segment by Specification
10ml:5mg
2ml:1mg
Others
Segment by Application
Hospitals and Clinics
Ambulatory Surgery Centers
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alfentanil Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alfentanil Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Specification, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Alfentanil Hydrochloride Injection Market Overview
1.1 Product Definition
1.2 Alfentanil Hydrochloride Injection by Specification
1.2.1 Global Alfentanil Hydrochloride Injection Market Value Comparison by Specification (2024-2030)
1.2.2 10ml:5mg
1.2.3 2ml:1mg
1.2.4 Others
1.3 Alfentanil Hydrochloride Injection by Application
1.3.1 Global Alfentanil Hydrochloride Injection Market Value by Application (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgery Centers
1.4 Global Alfentanil Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Alfentanil Hydrochloride Injection Revenue 2019-2030
1.4.2 Global Alfentanil Hydrochloride Injection Sales 2019-2030
1.4.3 Global Alfentanil Hydrochloride Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Alfentanil Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Alfentanil Hydrochloride Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Alfentanil Hydrochloride Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Alfentanil Hydrochloride Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Alfentanil Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alfentanil Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alfentanil Hydrochloride Injection, Product Type & Application
2.7 Global Key Manufacturers of Alfentanil Hydrochloride Injection, Date of Enter into This Industry
2.8 Global Alfentanil Hydrochloride Injection Market Competitive Situation and Trends
2.8.1 Global Alfentanil Hydrochloride Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Alfentanil Hydrochloride Injection Players Market Share by Revenue
2.8.3 Global Alfentanil Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alfentanil Hydrochloride Injection Market Scenario by Region
3.1 Global Alfentanil Hydrochloride Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Alfentanil Hydrochloride Injection Sales by Region: 2019-2030
3.2.1 Global Alfentanil Hydrochloride Injection Sales by Region: 2019-2024
3.2.2 Global Alfentanil Hydrochloride Injection Sales by Region: 2025-2030
3.3 Global Alfentanil Hydrochloride Injection Revenue by Region: 2019-2030
3.3.1 Global Alfentanil Hydrochloride Injection Revenue by Region: 2019-2024
3.3.2 Global Alfentanil Hydrochloride Injection Revenue by Region: 2025-2030
3.4 North America Alfentanil Hydrochloride Injection Market Facts & Figures by Country
3.4.1 North America Alfentanil Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Alfentanil Hydrochloride Injection Sales by Country (2019-2030)
3.4.3 North America Alfentanil Hydrochloride Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alfentanil Hydrochloride Injection Market Facts & Figures by Country
3.5.1 Europe Alfentanil Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Alfentanil Hydrochloride Injection Sales by Country (2019-2030)
3.5.3 Europe Alfentanil Hydrochloride Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alfentanil Hydrochloride Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Alfentanil Hydrochloride Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Alfentanil Hydrochloride Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Alfentanil Hydrochloride Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Alfentanil Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Latin America Alfentanil Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Alfentanil Hydrochloride Injection Sales by Country (2019-2030)
3.7.3 Latin America Alfentanil Hydrochloride Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Alfentanil Hydrochloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Alfentanil Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Alfentanil Hydrochloride Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Alfentanil Hydrochloride Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Specification
4.1 Global Alfentanil Hydrochloride Injection Sales by Specification (2019-2030)
4.1.1 Global Alfentanil Hydrochloride Injection Sales by Specification (2019-2024)
4.1.2 Global Alfentanil Hydrochloride Injection Sales by Specification (2025-2030)
4.1.3 Global Alfentanil Hydrochloride Injection Sales Market Share by Specification (2019-2030)
4.2 Global Alfentanil Hydrochloride Injection Revenue by Specification (2019-2030)
4.2.1 Global Alfentanil Hydrochloride Injection Revenue by Specification (2019-2024)
4.2.2 Global Alfentanil Hydrochloride Injection Revenue by Specification (2025-2030)
4.2.3 Global Alfentanil Hydrochloride Injection Revenue Market Share by Specification (2019-2030)
4.3 Global Alfentanil Hydrochloride Injection Price by Specification (2019-2030)
5 Segment by Application
5.1 Global Alfentanil Hydrochloride Injection Sales by Application (2019-2030)
5.1.1 Global Alfentanil Hydrochloride Injection Sales by Application (2019-2024)
5.1.2 Global Alfentanil Hydrochloride Injection Sales by Application (2025-2030)
5.1.3 Global Alfentanil Hydrochloride Injection Sales Market Share by Application (2019-2030)
5.2 Global Alfentanil Hydrochloride Injection Revenue by Application (2019-2030)
5.2.1 Global Alfentanil Hydrochloride Injection Revenue by Application (2019-2024)
5.2.2 Global Alfentanil Hydrochloride Injection Revenue by Application (2025-2030)
5.2.3 Global Alfentanil Hydrochloride Injection Revenue Market Share by Application (2019-2030)
5.3 Global Alfentanil Hydrochloride Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Piramal Pharma
6.1.1 Piramal Pharma Company Information
6.1.2 Piramal Pharma Description and Business Overview
6.1.3 Piramal Pharma Alfentanil Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Piramal Pharma Alfentanil Hydrochloride Injection Product Portfolio
6.1.5 Piramal Pharma Recent Developments/Updates
6.2 Yichang Humanwell Pharmaceutical
6.2.1 Yichang Humanwell Pharmaceutical Company Information
6.2.2 Yichang Humanwell Pharmaceutical Description and Business Overview
6.2.3 Yichang Humanwell Pharmaceutical Alfentanil Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Yichang Humanwell Pharmaceutical Alfentanil Hydrochloride Injection Product Portfolio
6.2.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
6.3 Hameln Pharma
6.3.1 Hameln Pharma Company Information
6.3.2 Hameln Pharma Description and Business Overview
6.3.3 Hameln Pharma Alfentanil Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hameln Pharma Alfentanil Hydrochloride Injection Product Portfolio
6.3.5 Hameln Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alfentanil Hydrochloride Injection Industry Chain Analysis
7.2 Alfentanil Hydrochloride Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alfentanil Hydrochloride Injection Production Mode & Process
7.4 Alfentanil Hydrochloride Injection Sales and Marketing
7.4.1 Alfentanil Hydrochloride Injection Sales Channels
7.4.2 Alfentanil Hydrochloride Injection Distributors
7.5 Alfentanil Hydrochloride Injection Customers
8 Alfentanil Hydrochloride Injection Market Dynamics
8.1 Alfentanil Hydrochloride Injection Industry Trends
8.2 Alfentanil Hydrochloride Injection Market Drivers
8.3 Alfentanil Hydrochloride Injection Market Challenges
8.4 Alfentanil Hydrochloride Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Piramal Pharma
Yichang Humanwell Pharmaceutical
Hameln Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂